Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting.
Saved in:
| Title: | Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting. |
|---|---|
| Authors: | Wobma H; Harvard Medical School, Boston, MA, United States.; Division of Immunology, Boston Children's Hospital, Boston, MA, United States., Henderson LA; Harvard Medical School, Boston, MA, United States.; Division of Immunology, Boston Children's Hospital, Boston, MA, United States., Duncan CN; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Prockop SE; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Randolph AG; Harvard Medical School, Boston, MA, United States.; Division of Critical Care, Boston Children's Hospital, Boston, MA, United States., Degar BA; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Lehmann LE; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Baumeister SHC; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Sep 19; Vol. 15, pp. 1631557. Date of Electronic Publication: 2025 Sep 19 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1631557 |
